Alain Fourquet < Alain Lortholary < Alain Ravaud

Facettes : Author.f AffPays.f AffRegion.f AffVille.f AffOrg.f Mesh.f MeshFr.f KwdFr.f

List of bibliographic references indexed by Alain Lortholary

Number of relevant bibliographic references: 6.

Ident.	Authors (with country if any)	Title
000006 (2023)	Xavier Pivot [France] ; Jean-Philippe Spano [France] ; Marc Espie [France] ; Christelle Jouannaud [France] ; Valerie Pottier [France] ; Laura Moreau [France] ; Jean Marc Extra [France] ; Alain Lortholary [France] ; Pascale Rivera [France] ; Dominique Spaeth [France] ; Zahira Mouri [France] ; Fella Tariket [France] ; Julien Dupin [France] ; Aurelien Berthois [France] ; Miruna Ionescu-Goga [France] ; Abdennour Ferhat [France] ; Paul Cottu [France] ; Joseph Gligorov [France]	Long Terms Follow-Up of the Randomized MetaspHER Study Comparing Intravenous Versus Subcutaneous Trastuzumab in Patients' With HER2-Positive Metastatic Breast Cancer.
000008 (2023)	Caroline Bailleux [France] ; Antoine Arnaud [France] ; Jean-S Xe9 Bastien Frenel [France] ; Sylvie Chabaud [France] ; Thomas Bachelot [France] ; Beno Xee T You [France] ; La Xeb Titia Stefani [France] ; Claire Garnier Tixidre [France] ; H Xe9 L Xe8 Ne Simon [France] ; Dominique Beal-Ardisson [France] ; Jean-Philippe Jacquin [France] ; Francesco Del Piano [France] ; Alain Lortholary [France] ; Claudiu Cornea [France] ; Charlotte Greilsamer [France] ; R Xe9 My Largillier [France] ; Fabien Brocard [France] ; Eric Legouffe [France] ; Mustapha Atlassi [France] ; Anne-Claire Hardy-Bessard [France] ; Pierre-Etienne Heudel [France]	CHEOPS trial: a GINECO group randomized phase II assessing addition of a non-steroidal aromatase inhibitor to oral vinorelbine in pre-treated metastatic breast cancer patients.
000014 (2022)	Olivier Tr Xe9 Dan [France] ; Magali Provansal [France] ; Cyril Abdeddaim [France] ; Audrey Lardy-Cleaud [France] ; Anne-Claire Hardy-Bessard [France] ; Elsa Kalbacher [France] ; Anne Floquet [France] ; Laurence Venat-Bouvet [France] ; Alain Lortholary [France] ; Oana Pop [France] ; Jean-S Xe9 Bastien Frenel [France] ; Mathilde Cancel [France] ; R Xe9 My Largillier [France] ; Christophe Louvet [France] ; Beno Xee T You [France] ; Alain Zannetti [France] ; Amelie Anota [France] ; Isabelle Treilleux [France] ; Daniel Pissaloux [France] ; Aur Xe9 Lie Houlier [France] ; Aude-Marie Savoye [France] ; Marie-Ange Mouret-Reynier [France] ; J Xe9 R Xf4 Me Meunier [France] ; Charles-Briac Levach Xe9 [France] ; Fabien Brocard [France] ; Isabelle Ray-Coquard [France]	Regorafenib or Tamoxifen for platinum-sensitive recurrent ovarian cancer with rising CA125 and no evidence of clinical or RECIST progression: A GINECO randomized phase II trial (REGOVAR).
000015 (2022)	Florence Joly [France] ; Michel Fabbro [France] ; Dominique Berton [France] ; Justine Lequesne [France] ; Am Xe9 Lie Anota [France] ; Alicja Puszkiel [France] ; Anne Floquet [France] ; H Xe9 L Xe8 Ne Vegas [France] ; Hugues Bourgeois [France] ; Le Xef La Bengrine Lefevre [France] ; Beno Xee T You [France] ; Fanny Pommeret [France] ; Alain Lortholary [France] ; Dominique Spaeth [France] ; Anne-Claire Hardy-Bessard [France] ; Cyril Abdeddaim [France] ; Marie-Christine Kaminsky-Forrett [France] ; Michel Tod [France] ; Jean-Emmanuel Kurtz [France] ; Francesco Del Piano [France] ; J Xe9 R Xf4 Me Meunier [France] ; Nadia Raban [France] ; J Xe9 Rome Alexandre [France] ; Marie-Ange Mouret-Reynier [France] ; Isabelle Ray-Coquard [France] ; Magali Provansal Gross [France] ; Pierre-Emmanuel Brachet [France]	Paclitaxel with or without pazopanib for ovarian cancer relapsing during bevacizumab maintenance therapy: The GINECO randomized phase II TAPAZ study.
000018 (2022)	Jean-David Fumet [France] ; Emilie Lardenois [France] ; Isabelle Ray-Coquard [France] ; Philipp Harter [Allemagne] ; Florence Joly [France] ; Ulrich Canzler [Allemagne] ; Caroline Truntzer [France] ; Olivier Tredan [France] ; Clemens Liebrich [Allemagne] ; Alain Lortholary [France] ; Daniel Pissaloux [France] ; Alexandra Leary [France] ; Jacobus Pfisterer [Allemagne] ; Alexandre Eeckhoutte [France] ; Felix Hilpert [Allemagne] ; Michel Fabbro [France] ; Christophe Caux [France] ; J Xe9 R Xf4 Me Alexandre [France] ; Aur Xe9 Lie Houlier [France] ; Jalid Sehouli [Allemagne] ; Emilie Sohier [France] ; Rainer Kimmig [Allemagne] ; Bertrand Dubois [France] ; Dominique Spaeth [France] ; Isabelle Treilleux [France] ; Jean-S Xe9 Bastien Frenel [France] ; Uwe Herwig [Allemagne] ; Olivia Le Saux [France] ; Nathalie Bendriss-Vermare [France] ; Andreas Du Bois [Allemagne]	Genomic Instability Is Defined by Specific Tumor Microenvironment in Ovarian Cancer: A Subgroup Analysis of AGO OVAR 12 Trial.
000028 (2020)	Anne-Claire Hardy-Bessard [France] ; Fabien Brocard [France] ; Florian Clatot [France] ; Alain Lortholary [France] ; Beno Xee T You [France] ; Julien Grenier [France] ; J Xe9 R Xf4 Me Martin-Babau [France] ; Brigitte Lucas [France] ; J Xe9 R Xf4 Me Meunier [France] ; Jean-Marc Ferrero [France] ; Aude-Marie Savoye [France] ; Adina Marti [France] ; Raymond Despax [France] ; Isabelle Moullet [France] ; George Emile [France]	First-line bevacizumab and eribulin combination therapy for HER2-negative metastatic breast cancer: Efficacy and safety in the GINECO phase II ESMERALDA study.

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/GentillyOncoV1/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Author.i -k "Alain Lortholary" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Author.i  \
                -Sk "Alain Lortholary" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    GentillyOncoV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Author.i
   |clé=    Alain Lortholary
}}

---

This area was generated with Dilib version V0.6.39. Data generation: Thu Feb 8 07:40:56 2024. Site generation: Thu Feb 8 07:42:40 2024